Celcuity Inc. financial data

Symbol
CELC on Nasdaq
Industry
Services-Medical Laboratories
Location
16305 36 Th Avenue N, Suite 100, Minneapolis, Minnesota
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Celcuity LLC (to 9/15/2017)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.33 K % -34.5%
Debt-to-equity 41.7 % +18.5%
Return On Equity -61.7 % -22.9%
Return On Assets -43.5 % -17.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.5 M shares +40.4%
Common Stock, Shares, Outstanding 30.8 M shares +40.3%
Entity Public Float 191 M USD +99%
Common Stock, Value, Issued 30.8 K USD +40.3%
Weighted Average Number of Shares Outstanding, Basic 33.6 M shares +55%
Weighted Average Number of Shares Outstanding, Diluted 33.6 M shares +55%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 70 M USD +75.5%
General and Administrative Expense 6.21 M USD +36.3%
Operating Income (Loss) -76.2 M USD -71.4%
Nonoperating Income (Expense) -250 K USD +41.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -73.5 M USD -65.5%
Net Income (Loss) Attributable to Parent -73.5 M USD -65.5%
Earnings Per Share, Basic -2.78 USD/shares -4.51%
Earnings Per Share, Diluted -2.78 USD/shares -16.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.2 M USD -7.21%
Other Assets, Current 9.86 M USD
Assets, Current 188 M USD +14.3%
Property, Plant and Equipment, Net 306 K USD +37%
Operating Lease, Right-of-Use Asset 352 K USD -36.2%
Assets 188 M USD +14.1%
Accounts Payable, Current 5.28 M USD +105%
Accrued Liabilities, Current 11.2 M USD +270%
Liabilities, Current 16.7 M USD +188%
Operating Lease, Liability, Noncurrent 182 K USD -50%
Liabilities 54.4 M USD +30.7%
Retained Earnings (Accumulated Deficit) -182 M USD -67.9%
Stockholders' Equity Attributable to Parent 134 M USD +8.53%
Liabilities and Equity 188 M USD +14.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.1 M USD -32.6%
Net Cash Provided by (Used in) Financing Activities 14.1 M USD +20627%
Net Cash Provided by (Used in) Investing Activities 3.54 M USD -83.8%
Common Stock, Shares Authorized 65 M shares 0%
Common Stock, Shares, Issued 30.8 M shares +40.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 870 K USD +16.5%
Deferred Tax Assets, Valuation Allowance 36.1 M USD +59.9%
Operating Lease, Liability 411 K USD +62.6%
Depreciation 29.6 K USD -32.7%
Payments to Acquire Property, Plant, and Equipment 89.7 K USD +1183%
Lessee, Operating Lease, Liability, to be Paid 508 K USD +83.8%
Property, Plant and Equipment, Gross 2.09 M USD +5.62%
Operating Lease, Liability, Current 182 K USD -6.68%
Lessee, Operating Lease, Liability, to be Paid, Year Two 220 K USD +217%
Lessee, Operating Lease, Liability, to be Paid, Year One 214 K USD +3.18%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +25%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 97.2 K USD +311%
Lessee, Operating Lease, Liability, to be Paid, Year Three 74.2 K USD
Deferred Tax Assets, Operating Loss Carryforwards 8.46 M USD +20.1%
Preferred Stock, Shares Issued 505 K shares -53.9%
Preferred Stock, Shares Authorized 2.5 M shares 0%
Operating Lease, Payments 309 K USD +9.51%
Additional Paid in Capital 315 M USD +36.3%
Preferred Stock, Shares Outstanding 505 K shares -53.9%
Interest Expense 5.49 M USD +88.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%